The cancer immunothrapy developer has filed to raise up to $100m in an offering that will follow $211m from backers including Celgene and Bristol-Myers Squibb.

The acquisition of insurance marketplace CoverHound comes after $112m in funding from investors including Hiscox, Chubb, MS&AD, Aflac Ventures, Ace Group and American Family Ventures.

Susquehanna International Group is set to exit the marketing collaboration software developer having invested just over a year ago.

First Data and Salesforce Ventures are set to exit the digital commerce technology provider after it agreed to be purchased for $440m in cash and stock.

China-based financial services provider Ant Group, spun off by e-commerce group Alibaba, intended to float on the Shanghai and Hong Kong stock markets.

The Baidu and Tencent-backed video streaming platform developer has filed for a Hong Kong offering that could potentially value it at $50bn.

Takeda Ventures and Chiesi Ventures are set to exit the cancer drug developer through the deal, which came after just over $200m in funding.

WuXi AppTec and Juno Therapeutics' joint cancer immunotherapy venture has listed on the Hong Kong Stock Exchange.

Rakuten Alphabet and Progressive are in line for exits after the automated lending service filed to go public yesterday.

Sana Biotechnology has bought central nervous system therapy developer and portfolio company Oscine, which is founded on University of Rochester research.